Revenue Comes in Weaker Than Expected
Edwards Lifesciences said third-quarter revenue was about $448 million, below its earlier guidance of $465 million to $485 million. Management cited weak demand in Europe, and EW is lower by 14 percent before the bell on my tradeMONSTER platform.
RadioShack Finds Favor at Bank of America
Bank of America Merrill Lynch upgraded RadioShack to "buy," citing valuation and saying that all the bad news is now priced into the stock. Its price target is $2.50. RSH, which closed at $2.08 yesterday and has lost four-fifths of its value in the last year, rose 12 percent in early trading.
Questcor Upgraded by Jefferies
Questcor Pharmaceuticals was raised to "buy" at Jefferies, which sees little downside risk after a big drop in the last month. The target price is $28. QCOR rose 4.5 percent in the premarket.
